2021 ASCO Virtual Direct™ Highlights
2021 ASCO Updates on EBC: Olaparib in gBRCA1/2m HER2- Disease, Capecitabine vs. Platinum Chemo for TNBC, Neoadjuvant Trastuzumab/Pertuzumab +/- Taxane for HER2+ BC
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Hatem Soliman
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Hatem Soliman
Login to view comments.
Click here to Login